#40S&P 500 rank

AMAT — Applied Materials, Inc.

Strong Growth, Still a Rich Multiple

Applied Materials beat Q3 FY26 estimates as AI chip-equipment demand accelerates, but its valuation stays well above history.

2-yr score: 66.4/100 (Top 10%)Technology
$408.94+0.98%
Description

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors.

Score breakdownLatest quarter74.5 · Good
Growth
73.3
Quality / Profitability
64.9
Financial health
87.9
Ratio screener
77.0
Track record: 2-yr avg 66.4 (Good, 8 quarters ≈ 2 yrs) · long-term avg 64.7 (Good, 40 quarters ≈ 10 yrs) · next earnings Nov 12, 2026 (in 21 days)(estimated)
Valuation context (informational only — not part of the score)
Rich vs. its own history
Entry timing (informational only — not part of the score)
Favorable (oversold / below trend)
Live market dataPrice updated Oct 21, 4:23 PM ET
P/E (TTM)
35.0
Yield
0.40%
RSI (14)
31.0
vs SMA20
-15.01%
vs SMA50
-13.91%
vs SMA200
-7.29%
Analyst target
$640
+56.5%
15 analysts
AI theoretical price
$407
-0.5%
as of 2026-10-16

Price chart & technical analysis

Loading chart…

AI deep-dive analysisAnalysis as of 2026-10-16 - price/technical figures below reflect that date, not live market data

As of 2026-10-16, AMAT trades at $416.25 after a brutal week (-17.8%) and a roughly 42% drawdown from its June 2026 high near $723, triggered by management withholding near-term wafer fab equipment targets at SEMICON West. The business itself is accelerating: Q3 FY26 revenue rose 24.8% year-over-year to $9.12B with operating margin expanding to 33.7%.

AI sentimentBearish

Near-term market sentiment is clearly bearish, and the price action makes that unambiguous: AMAT fell 17.78% in the week into 2026-10-16 and 21.29% over three months, with RSI at 30.46 and the shares 15.05% below their 20-day moving average. The proximate trigger was the October 2026 SEMICON West investor day, where management laid out attractive 2030 targets (54% non-GAAP gross margin, 40% non-GAAP operating margin, $12B+ services revenue) but declined to give explicit near-term WFE spending guidance - a visibility gap investors punished. Note the disconnect: sell-side ratings remain overwhelmingly constructive (43 Buy/Strong Buy vs. 12 Hold, zero Sells, consensus target near $640-660), so what has broken is the multiple and the momentum crowd, not the earnings estimates. This is sentiment rotating out of a crowded AI-cap-exposed name, not a fundamental miss.

Quarterly trend

The three-year arc is a textbook cyclical inflection rather than a steady compounder. Revenue sat in a flat $6.65-6.78B band through FY2024, then went sideways-to-soft into FY2025 ($7.05B, $7.17B, $7.10B, $7.30B) before dipping to $6.80B in the October 2025 quarter. From there the ramp is steep and sequential: $7.01B (+3.1% q/q), $7.91B (+12.8%), $9.12B (+15.2%). Year-over-year growth tells the same story of inflection: -3.5% (Oct '25), -2.1% (Jan '26), +11.4% (Apr '26), +24.8% (Jul '26). Margins confirm it. Gross margin has climbed from 47.1% in the October 2023 quarter to 50.3% in the July 2026 quarter (+320bp), and operating margin from 29.3% to 33.7%, with the four most recent prints reading 25.2% -> 29.9% -> 31.9% -> 33.7%. The 25.2% in the October 2025 quarter was a trough blip, not a trend break. One item worth flagging so it isn't misread: GAAP diluted EPS fell from $3.51 in the April 2026 quarter to $3.17 in July 2026 even though revenue rose 15.2% sequentially and operating income jumped 21.9% ($2.523B to $3.075B). The April quarter carried an unusually high 35.5% net margin versus 27.8% in July, indicating a below-the-line one-off lift rather than any deterioration in the core business - underlying profitability improved, and management guided Q4 FY26 EPS to $3.82-$4.22. The same pattern appears earlier: the January 2025 quarter showed $2.175B of operating income but only $1.185B of net income, a roughly $1B one-time charge. Strip those two items out and the earnings progression is clean and getting cleaner.

Valuation assessment

Expensive relative to its own history, and only reasonable relative to growth if you believe the AI-driven capex cycle extends for years. As of 2026-10-16, AMAT trades at 35.7x trailing EPS of $11.671 versus a five-year average P/E of 19.46x, and at 10.7x trailing sales versus a five-year average P/S of 4.97x - roughly double its own historical norms on both measures. P/B is 12.9x (inflated by a buyback-shrunk equity base of $25.6B), EV/EBITDA is 28.9x. On the provided next-fiscal-year EPS estimate of $12.815, the forward P/E is 32.5x - still far above the historical average. The headline PEG of 0.928 looks cheap, but only because it assumes something close to 38% forward growth; that is not a durable growth rate for a capital-equipment company. Caveat on the data: the next-FY revenue estimate of $34.34B is internally inconsistent with the current run-rate (FY2026 revenue will land near $33.5B), implying only ~2% growth and suggesting the consensus figures are stale and have not caught up to the July quarter's 24.8% growth. My read: the sell-side targets near $640-660 look anchored to the pre-selloff price rather than to a defensible multiple, and a round of downward target revisions is a live risk.

Price vs. earnings playbook

The key point is that this is a multiple reset, not an estimate reset. Estimates have been going up - Q3 FY26 beat consensus ($9.12B revenue vs. $8.99B expected; $3.50 non-GAAP EPS vs. $3.40) and Q4 guidance of $3.82-$4.22 implies another strong sequential step - while the stock has fallen 21% in three months. That combination resolves only one way: the market is repricing what it will pay for the earnings, not doubting the earnings. At the June 2026 peak near $723, AMAT was being valued at roughly 55x a ~$13 GAAP EPS year. At $416.25 it is at 35.7x trailing and roughly 31-32x the full FY2026 GAAP run-rate. The practical question for a buyer is whether the multiple stabilizes in the high-20s to low-30s. If Q4 delivers within guidance on 2026-11-12 and management restores any form of near-term WFE framework, the estimate path supports the multiple and the setup improves materially. If the multiple keeps compressing toward the 19.5x five-year average while estimates rise, price can keep falling even on good news - which is exactly what the last three months demonstrated.

Technical picture

As of 2026-10-16, the technical structure is broken. RSI(14) stood at 30.46 - near oversold, but not at the capitulation readings below 25 that often mark tradeable lows. The price of $416.25 sat 15.05% below the 20-day SMA (roughly $490), 13.57% below the 50-day SMA (roughly $482), and 5.05% below the 200-day SMA (roughly $438). The ordering matters: the 20-day is above the 50-day, which is above the 200-day, with price below all three - a rolling-over structure where the long-term trend line has just been lost. Returns of -17.78% over one week and -21.29% over three months sit against +5.03% over six months, meaning a violent unwind inside a still-positive longer arc. Implication for entry timing: mean-reversion bounces are common from RSI ~30, but the $438-490 band is now overhead resistance and every rally into it invites supply. There is no technical evidence yet of a bottom - a reclaim of the 200-day near $438 is the first thing to look for, not a reason to front-run it. This is a knife that has stopped falling fast but has not stabilized.

Macro factors
  • AI datacenter capex supercycle: hyperscaler and foundry spending on gate-all-around logic, high-bandwidth memory and advanced packaging is the direct demand driver for AMAT's deposition, etch and planarization tools, and it is the single biggest reason revenue growth inflected from -2.1% to +24.8% year-over-year across FY2026.
  • Export controls and China exposure: China has already fallen from roughly 35% of revenue to about 28% as tighter trade-compliance rules bite, and any further restriction is a structural headwind that cannot be offset by growth elsewhere in the same quarter.
  • Physical supply constraints: management has explicitly flagged clean room availability, energy limits and supply-chain lead times - demand is not the binding constraint on this cycle, and that caps how quickly AMAT can convert orders into revenue.
  • Rate sensitivity and high-multiple tech rotation: with a beta of 1.591, AMAT amplifies market moves roughly 1.6x, and a 35.7x trailing P/E makes it disproportionately vulnerable to any rotation away from long-duration growth equities.
  • Semiconductor capital-equipment cyclicality: WFE spending is historically boom-bust, and the durability of this upcycle depends on memory and logic producers maintaining capex discipline rather than reverting to the overbuild pattern that has ended every prior cycle.
Key catalysts
  • Q4 FY2026 earnings on 2026-11-12 (estimated), with guidance of $3.82-$4.22 in EPS and management expected to be quizzed hard on FY2027 WFE visibility and gross margin trajectory.
  • Restoration of near-term wafer fab equipment spending targets: management withheld explicit guidance at the October 2026 SEMICON West investor day, and closing that visibility gap would directly address the reason the stock sold off.
  • EPIC Center ramp in Silicon Valley - the $5B Equipment and Process Innovation and Commercialization hub, with named collaborations including Intel, UCLA, Kioxia and Besi, and utilization milestones that could validate the 2030 targets.
  • Progress on the AIX platform's connected-chamber network, targeting more than 90,000 chambers by 2030, alongside the stated goal of $12B+ in services revenue - both are higher-margin, more recurring revenue mix shifters.
  • Any loosening (or further tightening) of US export-control policy toward China, which would move the roughly 28% China revenue base in either direction.
Key risks
  • Multiple compression is the dominant risk right now: trailing P/E of 35.7x and P/S of 10.7x are roughly twice the five-year averages of 19.46x and 4.97x, and the last three months prove price can fall hard while earnings estimates rise.
  • A cyclical downturn in wafer fab equipment spending - AMAT's revenue is levered to memory and logic capex, and with a beta of 1.591 the drawdown would be amplified relative to the broader market.
  • China and export controls: China revenue has already compressed from roughly 35% to 28% of total, and further restrictions would remove revenue that cannot be backfilled quickly.
  • Supply-side bottlenecks (clean room availability, power/energy limits, extended lead times) could cap revenue conversion and push out the delivery of already-booked demand.
  • Stale sell-side expectations: with consensus targets clustered around $640-660 against a $416.25 price, target cuts from firms like Needham ($580) and Evercore ISI ($590) look like the start of a reset rather than the end, and further downward revisions would weigh on sentiment.
Investment thesis

Applied Materials is a genuinely high-quality franchise in an accelerating upcycle - 24.8% year-over-year revenue growth in the July 2026 quarter, operating margin expanding to 33.7%, gross margin at a three-year high of 50.3%, 22% ROIC, 34.3% ROE, net cash on the balance sheet and a current ratio of 2.42 - and the roughly 42% drawdown from June 2026 highs has done real work on the valuation. But it has not done enough. At $416.25 on 2026-10-16 the stock still trades at 35.7x trailing earnings and 10.7x sales, both about double their own five-year averages, and the technical structure has broken with price below the 20-, 50- and 200-day moving averages. My own fair-value work lands near $407, essentially at the current price. That is not a sell signal - this is a better risk/reward than it was at $723 - but it is not a compelling entry either. The honest setup is a great business at a full price, where the next leg higher depends on the multiple stabilizing; watch the 2026-11-12 print and whether Q4 lands in the $3.82-$4.22 guidance range before adding.

AI theoretical price methodology

Blended forward-multiple approach. I built FY2027E revenue of roughly $39B (about 15% above the ~$33.5B FY2026 run-rate implied by three reported quarters plus Q4), applied a 32% net margin - below the 33.7% Q3 FY26 operating margin once tax is applied, but above the 30.1% trailing net margin given the mix shift toward services - to get roughly $12.5B of net income, or about $15.75 per share on ~790M shares. At 25x forward EPS (above AMAT's 19.46x five-year average, reflecting the higher-margin services mix and AI capex leverage, but well below both the 35.7x trailing multiple and the ~55x implied at the June 2026 peak) that gives $394, weighted 65%. The remaining 35% uses 22x on FY2027E EBITDA of about $15.4B plus $1.8B of net cash, divided by 790M shares, giving roughly $431. The 65/35 blend produces $407, roughly 2% below the 2026-10-16 price of $416.25 - i.e. the stock is approximately fairly valued after the drawdown, not the deep discount the $640-660 sell-side consensus implies.

AI lean: Cautiously BullishConfidence: Medium
AI review of the deterministic score
Agree

I largely concur with the 74.5 / Good Fundamentals read, and I would nudge it higher, not lower - so the gap is well inside the threshold for Agree. The formula's structural blind spot is exactly the one flagged in the instructions: growth is measured on trailing year-over-year, which includes the January 2026 quarter's -2.1% revenue growth and drags the growth leg down, while the two most recent quarters printed +11.4% and +24.8% with sequential acceleration of +3.1%, +12.8%, +15.2%. That is a backward-looking penalty on a company that has already inflected, and I would add roughly 4-6 points to the growth component if the most recent two quarters were weighted properly. Quality/profitability at 64.9 also looks slightly harsh given operating margin has expanded from 25.2% to 33.7% over four quarters, gross margin has risen 320bp over three years, ROIC is 22% and the accruals ratio of -1.15% (as of 2026-07-26) confirms cash flow is running ahead of reported profit. Financial health at 87.9 is fair - $7.04B of cash against $5.25B of long-term debt, 0.287 debt-to-equity, 2.42 current ratio - and 15% is an appropriately modest weight for it. The 'Rich vs. its own history' valuation overlay is also correct as stated: P/E of 35.7x against a 19.46x five-year average and P/S of 10.7x against 4.97x. Note that the ratio screener's P/B of 12.994 and P/C of 36.1 are inflated by a buyback-shrunk equity base and say more about capital return policy than about overvaluation. I did not identify any single dated material event - no acquisition, bankruptcy, restatement or fraud - that would justify deviating from the band/valuation mapping, so Cautiously Bullish is the correct lean by the table.

AI-generated analysis for informational purposes only, not financial advice.